Dr. Reinaldo E. Rampolla, MD

Dr. Rampolla practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Rampolla's NPI, 1386645356, was assigned on August 2, 2005. Dr. Rampolla graduated from University of Puerto Rico, Medical Sciences Campus in 2000. Dr. Rampolla holds California license A101132.

Dr. Rampolla's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Rampolla's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Rampolla to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rampolla practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Rampolla's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Rampolla is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Rampolla's licenses on file in 4 states: California, Louisiana, Alabama and Puerto Rico.

Dmand AI lists bronchitis, chronic lung disease and pulmonary fibrosis among the conditions Dr. Rampolla treats.

CMS data shows 1,322 Medicare services from Dr. Rampolla across 12 procedure codes in 2024, for 168 Medicare patients. Medicare paid $96,073 for them.

CMS counts 168 Medicare patients who saw Dr. Rampolla in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 42% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rampolla's median patient age at 65, with 41% women.

In 2024, Dr. Rampolla wrote 3,462 Medicare Part D claims for 177 patients. 86% of them were for generic drugs. CMS names the drug for 3,136 of them, across 57 drugs with 11 or more claims each, at $1,123,716 in total drug cost. In 2023, CMS named 2,924 claims across 55 drugs.

Dr. Rampolla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Rampolla, published from 2015 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Lung and Lung Transplantation. Dr. Rampolla has published most often in J Heart Lung Transplant. Dr. Rampolla's most frequent co-authors are Ambalavanan Arunachalam, MD, Sangeeta Bhorade, MD and Howard Jeng Huang, MD.

CMS Open Payments shows 80 general payments to Dr. Rampolla from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Astellas Pharma US Inc paid the most, $9,531.

Dmand AI lists 1 award for Dr. Rampolla, most recently CMS Stage 1 EHR in 2013.

Dr. Rampolla graduated from University of Puerto Rico, Medical Sciences Campus in 2000. Dr. Rampolla is a member of ACCP, American Society of Transplantation, ATS and The International Society for Heart and Lung Transplantation.

Dr. Rampolla is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.